CADONILIMAB
UNII 6FYG1DS4NW

Substance Identification & Data

This profile provides standardized clinical and technical data for Cadonilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6FYG1DS4NW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2394841-59-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6FYG1DS4NW

CAS Registry Number

2394841-59-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CADONILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C153379

National Cancer Institute reference terminology for clinical and research data.

INN ID

11581

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-159

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cadonilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CADONILIMAB

Common Names & Synonyms

ANTI-PD1/ANTI-CTLA4 BISPECIFIC ANTIBODY AK104

CADONILIMAB [INN]

CADONILIMAB [USAN]

CADONILIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (235-ALANINE,236-ALANINE,238-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-MUS MUSCULUS .KAPPA.-CHAIN V-J REGION), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER

PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR AK104